Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is expressed in the
liver and secreted as biliary glycoprotein 1 (BGP1) via bile canaliculi (BCs). CEACAM1-LF is …

Abstract Objective Although Ceacam1−/− male mice become obese on normal chow, the
effect of bone marrow transplantation or introduction of the carcinoembryonic antigen …

Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) regulates insulin
sensitivity by promoting hepatic insulin clearance and mediating suppression of fatty acid …

Impairment of insulin clearance is being increasingly recognized as a critical step in the
development of insulin resistance and metabolic disease. The carcinoembryonic antigen …

Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) regulates insulin
sensitivity by promoting hepatic insulin clearance. Liver-specific inactivation or global null …

The pathogenesis of human non-alcoholic fatty liver disease (NAFLD) remains unclear, in
particular in the context of its relationship to insulin resistance and visceral obesity. Work on …

Nonalcoholic fatty liver disease (NAFLD), now renamed as metabolic dysfunction-
associated steatotic liver disease (MASLD), is a precursor or a hepatic manifestation of …

Background CEACAM1 regulates insulin sensitivity by promoting insulin clearance.
Accordingly, global C57BL/6J. Cc1−/− null mice display hyperinsulinemia due to impaired …

CEACAM1 promotes insulin extraction, an event that occurs mainly in liver. Phenocopying
global Ceacam1 null mice (Cc1–/–), C57/BL6J mice fed a high-fat (HF) diet exhibited …

Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is a
transmembrane glycoprotein that is expressed on epithelial, endothelial and immune cells …